Finance

Mga Listahan
Outlook: 85.2% bullish·0.0% bearish
Pumunta sa pagsusuri
CI:NYSE
Cigna Group
$282.43
+0.50%
(+1.40) 1D
$282.43
0.00% (0.00)
Pagkalipas ng oras ng trabaho
Sarado: Okt 9, 4:00:07 PM GMT-4  ·   USD
Lahat ng simbolo
SimboloPresyoPalitan% ng Pagbabago
Bumubuo ng mga nangungunang insight para sa CI...
Buksan
$281.16
Mataas
$287.89
Mababa
$280.46
Mkt. cap
74.63B
Avg. na dami
1.59M
Dami
885.42K
Dividend
2.21%
Bawat tatlong buwang dividend
$1.56
Petsa ng ex-dividend
Set 8, 2026
P/E ratio
11.71
Mataas nang 52-wk
$311.34
Mababa nang 52-wk
$239.51
EPS
$24.13
Beta
0.29
Mga natitirang share
264.24M
Bilang ng mga empleyado
67K
Buksan
$281.16
Mataas
$287.89
Mababa
$280.46
Mkt. cap
74.63B
Avg. na dami
1.59M
Dami
885.42K
Dividend
2.21%
Bawat tatlong buwang dividend
$1.56
Petsa ng ex-dividend
Set 8, 2026
P/E ratio
11.71
Mataas nang 52-wk
$311.34
Mababa nang 52-wk
$239.51
EPS
$24.13
Beta
0.29
Mga natitirang share
264.24M
Bilang ng mga empleyado
67K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Profile
The Cigna Group is an American multinational for-profit managed healthcare and insurance company based in Bloomfield, Connecticut. Cigna's insurance subsidiaries are major providers of medical, dental, disability, life and accident insurance and related products and services, the majority of which are offered through employers and other groups. Cigna is incorporated in Delaware. The company ranked No. 15 in the 2023 Fortune 500 list of the largest U.S. corporations by total revenue, and the company took 68th place in the 2023 Forbes Global 2000 ranking. It has been embroiled in controversies, including engaging in automatic denials of insurance claims without reviewing them. Wikipedia
Tungkol sa Cigna Group
CEO-
Mga Empleyado66.7K
Itinatag1792
HeadquartersBloomfield, Connecticut, Estados Unidos
SektorHealth care provider
Website-
Mga rating ng analyst
Batay sa 19 (na) analyst na nagbigay ng mga rating ng stock sa CI sa nakalipas na 3 buwan
Pagbili
Pagbili
13
Pag-hold
6
Pagbebenta
0
12 buwang forecas
Batay sa 19 (na) analyst sa Wall Street na nag-aalok ng mga target na presyo sa loob ng 12 buwan para sa CI sa nakalipas na 3 buwan.
Pinakamataas
Kasalukuyan $282.43
$387.00 (+37.03%)
Average
$338.89 (+19.99%)
Pinakamababa
$290.00 (+2.68%)
Analyst
Rekomendasyon
Aksyon
Target na presyo
Inaasahan
Petsa
Ben Hendrix
RBC Capital
Buy
Maintained
$337.00
+19.3%
10/07/2026
Lance Wilkes
Bernstein
Buy
Maintained
$387.00
+37%
10/05/2026
David S Macdonald
Truist Financial
Buy
Reiterated
$350.00
+23.9%
10/02/2026
Jessica Tassan
Piper Sandler
Buy
Maintained
$370.00
+31%
10/02/2026
Elizabeth Anderson CFA
Evercore ISI
Hold
Maintained
$290.00
+2.7%
10/01/2026
Unknown Analyst
Leerink Partners
Hold
Reiterated
$300.00
+6.2%
10/01/2026
Michael Wiederhorn
Oppenheimer
Buy
Maintained
$365.00
+29.2%
10/01/2026
Charles Rhyee
TD Cowen
Buy
Maintained
$338.00
+19.7%
09/30/2026
Stephen Baxter
Wells Fargo
Hold
Maintained
$307.00
+8.7%
09/30/2026
Kevin Fischbeck
Bank of America Securities
Buy
Reiterated
$378.00
+33.8%
10/01/2026
Andrew Mok CFA
Barclays
Hold
Maintained
$310.00
+9.8%
10/01/2026
Erin Wright
Morgan Stanley
Buy
Maintained
$361.00
+27.8%
09/29/2026
David Windley
Jefferies
Hold
Downgraded
$307.00
+8.7%
08/03/2026
Scott Fidel
Goldman Sachs
Buy
Maintained
$352.00
+24.6%
08/02/2026
Parker Snure
Raymond James
Buy
Maintained
$320.00
+13.3%
08/03/2026
Lisa Gill
J.P. Morgan
Buy
Maintained
-
-
07/30/2026
George Hill
Deutsche Bank
Hold
Maintained
$305.00
+8%
07/31/2026
Unknown Analyst
Oppenheimer
Buy
Maintained
$365.00
+29.2%
07/31/2026
Jailendra Singh
Truist Financial
Buy
Reiterated
$350.00
+23.9%
07/31/2026
Michael Ha
Robert W. Baird
Buy
Maintained
$362.00
+28.2%
07/31/2026
Jason Cassorla
Guggenheim
Buy
Maintained
$361.00
+27.8%
07/30/2026
Ann Hynes
Mizuho Securities
Buy
Maintained
$340.00
+20.4%
06/08/2026
A.J. Rice
UBS
Buy
Maintained
$400.00
+41.6%
05/22/2026
Unknown Analyst
Cantor Fitzgerald
Buy
Reiterated
$340.00
+20.4%
04/30/2026
Sarah James
Cantor Fitzgerald
Buy
Reiterated
$340.00
+20.4%
04/30/2026
Joanna Gajuk
Bank of America Securities
Buy
Maintained
$378.00
+33.8%
04/13/2026
Kevin Caliendo
UBS
Buy
Maintained
$375.00
+32.8%
02/09/2026
Huling ulat
Hul 30, 2026
Fiscal period
Q2 2026
$7.78 / $7.60
+2.37%lumampas
Kita / Pagtataya (USD)
71.67B / 70.18B
+2.12%lumampas
Earnings call para sa Fiscal Q2 2026
Hinihintay ang earnings call
Sa isang sulyap
Mga insight mula sa mga pinakabagong balita at ulat
Mga nakaraang ulatLahat ng value sa USD
Loading Previous Earnings...
Kita
Net na kita
Lahat ng value sa USD
Set 2025
Dis 2025
Mar 2026
Hun 2026
Kita
69.75B
72.47B
68.49B
71.67B
Gastusin sa mga naibentang produkto
63.37B
66.06B
62.02B
65.13B
Halaga ng kita
63.37B
66.06B
62.02B
65.13B
Mga gastos sa pananaliksik at pag-develop
-
-
-
-
Kabuuang gastos sa pananaliksik at pag-develop
-
-
-
-
Mga gastos sa pagbebenta, pangkalahatan, at admin
3.15B
3.40B
2.33B
3.29B
Gastos sa pagpapatakbo
3.59B
3.86B
2.72B
3.68B
Kabuuang gastos sa pagpapatakbo
66.96B
69.91B
64.74B
68.81B
Kita sa pagpapatakbo
2.79B
2.56B
3.75B
2.86B
Iba pang hindi kita sa pagpapatakbo
16.00M
-62.00M
-357.00M
3.00M
EBT na may mga hindi karaniwang item
2.30B
1.82B
2.27B
2.26B
EBT na hindi kasama ang mga hindi karaniwang item
2.44B
2.20B
3.40B
2.50B
Gastos sa buwis sa kita
322.00M
543.00M
409.00M
382.00M
Epektibong rate ng buwis
14.03%
29.88%
18.02%
16.93%
Iba pang gastos sa pagpapatakbo
-
-
-
-
Net na kita
1.87B
1.23B
1.65B
1.66B
Margin ng kabuuang kita
2.68%
1.70%
2.41%
2.32%
Kita bawat share
7.83
8.08
7.79
7.78
Kita sa interes at investment
-
-
-
-
Gastos sa interes
-363.00M
-300.00M
-
-359.00M
Mga net na gastos sa interes
-363.00M
-300.00M
-
-359.00M
Mga singil sa depreciation at amortization
-
-
-
-
EBITDA
3.49B
3.28B
4.40B
3.51B
Kita o pagkalugi mula sa pagbebenta ng mga asset
-38.00M
66.00M
-11.00M
-6.00M
Mga transaksyon ng insider
Kinukuha ang data ng mga insider na transaksyon mula sa mga third-party na source. Matuto pa
Insider
Posisyon
Uri
Petsa
Mga Share
Halaga
Page 1
Posibleng magkaroon ng mga pagkakamali ang AI content. Matuto pa
Mga app ng Google